The Institute

The Ontario Institute for Cancer Research (OICR) is an innovative translational research organization dedicated to research on the prevention, early detection, diagnosis and treatment of cancer. OICR was launched by the Government of Ontario in December 2005 to tackle the big questions in cancer research.


Translation of research findings into:

Products icon


Services icon


Improved Clinical Practice icon

Improved Clinical Practice


More than 1,700 researchers, clinican scientists, research staff and trainees in the MaRS Centre in Toronto and at Ontario's leading universities and hospital-based research institutes.


  • Activities strategically chosen to focus on areas of the highest potential impact on patients;
  • Builds on Ontario's existing global strengths involving researchers across the province - medical imaging, clinical trials, cancer stem cells and bio-therapeutics.
OICR Image

Stategic Research Plan

  • Facilitate adoption of personalized medicine for cancer;
  • Seek solutions to critical issues that could benefit patients in the next five years;
  • Enhance and facilitate the digitization and interpretation of cancer data.

Fight Against Cancer Innovation Trust

Established by OICR to better enable the commercial translation of OICR and Ontario's oncology innovations, the Fight Against Cancer Innovation Trust (FACIT) is OICR's strategic partner for technology transfer, partnerships and collaborations

Partnerships and Collaborations

  • California Institute for Regenerative Medicine;
  • Canadian Partnership Against Cancer;
  • Cancer Care Ontario;
  • Cancer Stem Cell Consortium;
  • GE Healthcare;
  • MaRS Innovation;
  • Janssen;
  • Canadian Cancer Trials Group;
  • Prostate Cancer Canada;
  • Stand Up to Cancer Canada.